Sales decline 48.03% to Rs 41.50 crore
Net Loss of Panacea Biotec reported to Rs 25.31 crore in the quarter ended March 2022 as against net loss of Rs 18.31 crore during the previous quarter ended March 2021. Sales declined 48.03% to Rs 41.50 crore in the quarter ended March 2022 as against Rs 79.86 crore during the previous quarter ended March 2021.For the full year,net loss reported to Rs 93.58 crore in the year ended March 2022 as against net loss of Rs 14.44 crore during the previous year ended March 2021. Sales declined 31.45% to Rs 235.50 crore in the year ended March 2022 as against Rs 343.56 crore during the previous year ended March 2021.
ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales41.5079.86 -48 235.50343.56 -31 OPM %-46.70-20.17 --30.860.14 - PBDT-18.25-10.22 -79 -67.1513.69 PL PBT-25.31-16.79 -51 -93.58-12.88 -627 NP-25.31-18.31 -38 -93.58-14.44 -548
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
